NCT05503875 Immunoclassification of Psoriasis: a Strategy for Precision Medicine
| NCT ID | NCT05503875 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Condition | Immunoclassification |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-01-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Through the combination of clinical manifestations and omics, the investigators aim to explore the skin cell atlas in different stages of psoriasis lesions, establish a clinical classification standard for psoriasis, and guide the precise treatment of psoriasis.
Eligibility Criteria
Inclusion Criteria: 1.18 to 75 years of age 2.Moderate to severe chronic psoriasis, BSA≥3% 3.Duration of psoriasis≥6 months 4.Patients must be candidate for systemic therapy 5.Informed consent must be obtained 6.For female, ß-hCG test is negative and contraception is accepted Exclusion Criteria: 1. Having severe infections, including hepatitis, HIV and tuberculosis 2. Having significant allergies to biological agents 3. Having a history of malignancy 4. Refusal of contraception 5. Having serious or unstable/uncontrolled illnesses
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05503875 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Immunoclassification. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05503875 currently recruiting?
Yes, NCT05503875 is actively recruiting participants. Contact the research team at manxy@zju.edu.cn for enrollment information.
Where is the NCT05503875 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT05503875 clinical trial?
NCT05503875 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The trial plans to enroll 100 participants.